1WM
FBIO icon

1900 Wealth Management’s Fortress Biotech FBIO Stock Holding History

1900 Wealth Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-27,200
Closed -$224K – 298
2023
Q2 		$224K Buy
27,200
+18,533
+214% +$183K 0.02% 226
2023
Q1 		$85.2K Hold
8,667
– – 0.01% 238
2022
Q4 		$85.2K Buy
8,667
+2,000
+30% +$22.1K 0.01% 232
2022
Q3 		$86K Buy
+6,667
New +$99.8K 0.01% 218

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

1900 Wealth Management's FBIO Position: Q3 2023 in Review

1900 Wealth Management sold out of Fortress Biotech (FBIO) in Q3 2023, closing a stake of 27,200 shares — an estimated $224K sold.

1900 Wealth Management first reported a position in FBIO in Q3 2022 and held it in 4 quarters. The position peaked at $224K in Q2 2023. 48 funds tracked by Wall St. Rank hold FBIO as of Q3 2023.

  • 1900 Wealth Management reported no remaining Fortress Biotech position as of Q3 2023 after selling out during the quarter.
  • 1900 Wealth Management sold 27,200 Fortress Biotech shares in Q3 2023, an estimated $224K.
  • 1900 Wealth Management first reported a position in Fortress Biotech in Q3 2022 and held it in 4 quarters.
  • 1900 Wealth Management's Fortress Biotech position peaked at $224K in Q2 2023.
  • 48 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2023.

Based on 1900 Wealth Management's 13F filing for Q3 2023, filed 17 Oct 2023.